Events & Presentations

Investors

Events & Presentations

Upcoming Events
Date Event Details Remind Me
Oct 18, 2019 8:00 AM EDT
Arrowhead Analyst R&D Day 2019
New York, NY
Archived Events
Date Event Details
Feb 4, 2014
Fiscal 2014 First Quarter Financial Results
Dec 18, 2013
Fiscal 2013 Fourth Quarter and Year End Financial Results
Dec 9, 2013
HepDART 2013

Phase 1, FIH clinical trial of ARC-520, an siRNA-based therapeutic for treatment of chronic HBV infection, in normal healthy volunteers.

Dec 4, 2013 1:30 AM EST
Piper Jaffray Healthcare Conference
Nov 19, 2013
Oligonucleotide & Peptide Based Therapeutics Congress

"Targeted delivery of therapeutic siRNAs using DPC technology"

 

Nov 14, 2013
EuroTIDES 2013

"DPC technology for delivery of therapeutic siRNAs”

Nov 3, 2013
AASLD – The Liver Meeting 2013

"ARC-520 RNAi therapeutic reduces HBV DNA, S and e antigen in a chimpanzee”

Oct 23, 2013
2013 International Meeting on Molecular Biology of Hepatitis B Viruses

"Kinetics of knockdown from RNAi therapeutic ARC-520 on hepatitis B virus RNA, DNA, S antigen and e antigen in mice and chimpanzee"

Aug 7, 2013
Fiscal 2013 Third Quarter Financial Results
Jun 26, 2013
European CLINAM and ETPN Summit

"A Novel Hepatitis B Treatment with RNAi"